![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
July 3, 2024
Summaries of recently published ECOG-ACRIN research results
June 11, 2024
Dustin A. “Dusty” Deming, MD, is the young investigator of the year for the ECOG-ACRIN Cancer Research Group
December 19, 2023
This randomized phase 3 trial is testing whether second-line treatment with hepatic arterial infusion and systemic chemotherapy is more effective than systemic chemotherapy alone
April 15, 2022
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
July 7, 2021
This phase II study will test the effect of nivolumab plus ipilimumab, with short-course radiation, for the neoadjuvant treatment of patients with low-lying, locally advanced MSI-H/dMMR rectal cancer